Transforming Pediatric Obesity Treatment

This chapter explores the surge in GLP-1 medication use for treating obesity in children, contrasting it with traditional options like metformin. It highlights the importance of the AAP guidelines and the necessity for open dialogues between families and healthcare providers. Additionally, the speaker shares personal experiences and insights on the future of obesity management, emphasizing the integration of evidence-based strategies and telehealth advancements.